超短脉冲电休克治疗抑郁症的系统综述与荟萃分析
该系统综述与荟萃分析纳入30项研究,评估超短脉冲ECT治疗抑郁症的急性与长期结局。超短脉冲高剂量右侧单侧ECT汇总缓解率为32.2%,治疗反应率45.3%,因疗效不足换用短脉冲ECT者占28.1%,缓解后6个月内复发或脱落者占44.1%。结论认为超短脉冲ECT急性结局不及传统短脉冲ECT,不能视为最先进ECT。
要点
- 超短脉冲高剂量右侧单侧ECT汇总缓解率仅32.2%,治疗反应率45.3%。
- 28.1%患者因疗效不足换用短脉冲ECT,缓解后6个月内44.1%复发或脱落。
- 超短脉冲ECT急性结局不及传统短脉冲ECT,不能视为最先进ECT。
核心结论
- 超短脉冲ECT治疗抑郁症的急性结局不及传统短脉冲ECT,不能视为最先进ECT。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Embase、PsycINFO、CENTRAL和ClinicalTrials.gov自2007年1月1日至2024年9月17日的随机对照试验和观察性研究。
- 共30项研究提供至少一个相关结局数据,采用随机效应模型汇总缓解率、反应率、复发率和换用其他ECT形式率。
主要发现
- 超短脉冲高剂量右侧单侧ECT汇总缓解率为32.2%(95% CI 26.1%-39.0%,k=23,n=1478)。
- 该形式ECT治疗反应率为45.3%(95% CI 39.0%-51.7%)。
- 因感知疗效不足换用短脉冲ECT者占28.1%(95% CI 20.6%-37.0%)。
- 超短脉冲高剂量右侧单侧ECT缓解后接受继续药物治疗者中,6个月内复发或脱落率为44.1%(95% CI 34.4%-54.3%)。
关键数值与推荐
- 超短脉冲高剂量右侧单侧ECT汇总缓解率32.2%(95% CI 26.1%-39.0%)。
- 超短脉冲高剂量右侧单侧ECT治疗反应率45.3%(95% CI 39.0%-51.7%)。
- 换用短脉冲ECT率28.1%(95% CI 20.6%-37.0%)。
- 缓解后6个月内复发或脱落率44.1%(95% CI 34.4%-54.3%)。
临床怎么用
- 临床选用超短脉冲ECT时应告知患者其缓解率和反应率低于传统短脉冲ECT。
- 对超短脉冲高剂量右侧单侧ECT疗效不足者,可考虑换用短脉冲ECT。
- 超短脉冲ECT缓解后仍需关注6个月内较高的复发或脱落风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ultrabrief pulse (<0.5 millisecond pulse width) electroconvulsive therapy (ECT) is regarded as a cognition-sparing form of ECT. Contrary to some early research, recent randomised trials have reported low remission rates with ultrabrief pulse high-dose right unilateral ECT. The aim of the present systematic review and meta-analysis was to assess acute and long-term outcomes following right unilateral and bilateral forms of ultrabrief pulse ECT in depression. We searched PubMed, Embase, PsycINFO, CENTRAL and ClinicalTrials.gov databases from 01 January 2007 to 17 September 2024 for randomised controlled trials and observational studies reporting on one or more relevant outcomes. Remission, response, relapse and switching rates to other forms of ECT were pooled using random effects models. 30 studies provided data on one or more outcomes. The pooled remission rate (k = 23, n = 1478) was 32.2% (95% CI 26.1%-39.0%) with ultrabrief pulse high-dose right unilateral ECT. Less than half of patients (45.3% [95% CI 39.0%-51.7%]) treated with this form of ECT achieved therapeutic response. Switching to brief-pulse ECT due to perceived inadequate response was common and occurred in 28.1% of patients (95% CI 20.6%-37.0%). Of remitters with ultrabrief pulse high-dose right unilateral ECT treated with continuation pharmacotherapy, 44.1% (95% CI 34.4%-54.3%) relapsed or withdrew within six months of completion of an acute course of ECT. The results of this meta-analysis indicate that acute outcomes following ultrabrief pulse ECT fall short of those expected with conventional brief-pulse ECT. As such, ultrabrief pulse ECT cannot be regarded as "state-of-the-art" ECT.
引用
- Jelovac A, McLoughlin DM. Ultrabrief pulse electroconvulsive therapy for depression: a systematic review and meta-analysis. Mol Psychiatry. 2025. PMID: 41206419. doi:10.1038/s41380-025-03327-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。